EAACI Congress 2025

13 - 16 June 2025 Glasgow, United Kingdom

Friday 13 Jun
Saturday 14 Jun
Sunday 15 Jun
Monday 16 Jun

Onsite
Synoptic

Scientific

	Clyde Auditorium	Meeting Academy M2	Poster Zone	Lomond Auditorium	Hall 1	Innovation Hub	Meeting Academy M1	Forth	Boisdale	Alsh	Carron 1	Carron 2	Dochart 1	Dochart 2	EAACI Global Stage	Poster Area	E-TPS Display Only Digital section


7:00
30
8:00											MTE1 - Clinical studies on allergen immunotherapy with inhaled allergens: optimization and standardization of methodological approaches	MTE2 - Tips and tricks for biological treatment of CRSwNP: setting the indication, choosing the right biological, managing side effects, switching, tapering	MTE3 - MTE3	MTE4 - MTE4			e-TPS Display Only
30	SY1 - Clinical impact of Immune mechanisms driving asthma			SY2 - Cofactor-dependent food-induced anaphylaxis	IWS1 - Managing venom allergy: what’s new	IH1 - AI in allergy and lung health: predicting the future, transforming diagnosis	IWS2 - Management of delayed drug hypersensitivity reactions	IWS3 - Omics		JMA 1 - Inborn errors of immunity: Increasing awareness in clinical practice
9:00									SSS 1 - EAACI & JSA Joint Symposium : New Insights into the Mechanism and Treatment Strategies for Unified Airway Disease		OAS25 - Oral Abstract Session 25	OAS26 - Oral Abstract Session 26	FT27 - Flash Talk Session 27	FT28 - Flash Talk Session 28
30
10:00
30	PL1 - Innovations and Emerging Therapies in Food Allergy: Bridging Research and Clinical Practice			PL2 - Infections and the Development of Allergy: Unraveling the Connections	PL3 - EAACI Highlight Plenary session Focus on Angioedema and Mast Cell Diseases
11:00
30
12:00		EAACI-COURSE - EAACI Course on immunology update : selected topics in basic and translational immunology	TPS20 - Pediatrics TPS24 - Ocular allergy TPS22 - Microbiome TPS19 - Infections TPS16 - Immune deficiencies and autoimmunity 01 TPS23 - Genomics and proteomics TPS10 - Food allergy 01 TPS12 - Drug allergy 02 TPS11 - Drug allergy 01 TPS15 - Dermatology 01 TPS21 - COVID19 TPS18 - Biologicals 01 TPS17 - Basic immunology 01 TPS07 - Asthma 02 TPS06 - Asthma 01 TPS14 - Anaphylaxis 02 TPS13 - Anaphylaxis 01 TPS05 - Allergy diagnosis 05 TPS04 - Allergy diagnosis 04 TPS03 - Allergy diagnosis 03 TPS02 - Allergy diagnosis 02 TPS01 - Allergy diagnosis 01 TPS09 - Allergen immunotherapy 02 TPS08 - Allergen immunotherapy 01				SSS 2 - EAACI & APAPARI Joint Symposium : Emerging concepts in the management of food allergies				OAS27 - Oral Abstract Session 27	OAS28 - Oral Abstract Session 28	FT29 - Flash Talk Session 29	FT01 - Mastocytosis and mast cells diseases	POC - Codex Alimentarius & Precautionary Allergen Labelling (PAL): A New Era for Food Safety and Patient Information	TPS - Poster Session
30
13:00
30	SY3 - Beyond the future - perspectives in the diagnosis and treatment of allergy and asthma			SY4 - Management of severe food allergy in children	EAACI Special Session 1 - NAIS Forum 2025 : Updates in Anaphylaxis	ET 1 - EAACI Enlightening Talks-1		GBD 1 - Ground breaking discoveries 1	JMA 2 - Nano- and new technologies in diagnosing and treating allergies		OAS01 - Occupational Allergy: back to the future	OAS02 - Biologics in the combined airway	FT02 - Anaphylaxis, new perspectives and treatments	FT03 - Urticaria and Angioedema	P & C 1 - Is premedication useful to prevent non-IgE mediated immediate drug hypersensitivity reactions
14:00
30															P & C 2 - Timing in oral immunotherapy : Early vs. Late introduction
15:00	SY5 - Climate change effects on allergic patients: Emerging environmental threats			SY6 - Utility of molecular allergology in diagnosis and management of complex sensitization profiles	TSY1 - Bi-directional neuro-immune communications controlling allergy	OAS-CT1 - Clinical Trials on Airways Diseases	JMA3 - JMA IWS : Mastering the art of research: Writing, publishing, and building your research team	IWS4 - Assessment of control in chronic rhinitis and CRS			OAS03 - Allergic diseases in the perspective of innate immune responses	OAS04 - Drug Allergy: from bench to bedside	FT04 - Epidemiology and clinical management of drug allergy	FT05 - Immunotherapy from patient and epidemiological study perspective
30
16:00
30
17:00				SY7 - Treating chronic inflammation in the upper airways	SY8 - Diet and Allergy	IH2 - AI and Education: shaping the future of allergy and respiratory health	TSY2 - Aril-hydrocarbon receptor (AhR) : regulation and impact on human health	IWS5 - Exploring the clinical management of Eosinophilic Esophagitis			OAS05 - Hereditary Angioedema	OAS06 - From Basic Immunology to translational applications	FT06 - Mechanisms and applications in allergy and asthma research	FT07 - Biologicals, biomarkers and microbiome
30
18:00
30	Opening Ceremony
19:00
30
20:00

Scientific

	Clyde Auditorium	Poster Zone	Lomond Auditorium	Hall 1	Innovation Hub	Meeting Academy M1	Forth	Boisdale	Alsh	Carron 1	Carron 2	Dochart 1	Dochart 2	EAACI Global Stage	Poster Area


7:00
30
8:00										MTE5 - Allergen immunotherapy for allergic disease: Indications and contraindications	MTE6 - Pathogenic mechanisms in the evolution of food allergy	MTE7 - Diversity of regulatory B cells: Markers and functions	MTE8 - Clinical Pathway on direct drug provocation testing
30	SY9 - Impact of natural disasters on respiratory and immune health			SY10 - Chronic spontaneous urticaria: latest clinical developments	IH3 - Nanotechnology in allergy: From diagnostics to precision therapies	IWS6 - Innovations in Betalactam allergy diagnosis			JMA4 - Year in review
9:00										OAS29 - Oral Abstract Session 29	OAS30 - Oral Abstract Session 30	FT30 - Flash Talk Session 30	FT31 - Flash Talk Session 31
30
10:00
30	PL4 - Drug Allergy: Advances in Diagnosis, Management, and Prevention		PL5 - Microbiota and Immune Regulation: Insights from Gut to Lungs Across the Lifespan	PL6 - Highlights of EAACI Guidelines: Latest Developments and Clinical Applications
11:00
30
12:00		TPS50 - Systems medicine TPS47 - Occupational allergy TPS49 - Immunomodulation and nutrition TPS40 - Immune deficiencies and autoimmunity 02 TPS35 - Food allergy 03 TPS34 - Food allergy 02 TPS46 - Epidemiology TPS44 - Environmental allergy and climate change + One health TPS43 - ENT TPS36 - Drug allergy 03 TPS39 - Dermatology 03 TPS38 - Dermatology 02 TPS42 - Biologicals 02 TPS41 - Basic immunology 02 TPS31 - Asthma 05 TPS30 - Asthma 04 TPS29 - Asthma 03 TPS37 - Anaphylaxis 03 TPS28 - Allergy diagnosis 09 TPS27 - Allergy diagnosis 08 TPS26 - Allergy diagnosis 07 TPS25 - Allergy diagnosis 06 TPS48 - AllergoOncology TPS33 - Allergen immunotherapy 04 TPS32 - Allergen immunotherapy 03 TPS45 - Aerobiology and pollution		SSS 3 - EAACI & SLAAI Joint Symposium : Air pollution In Latin America						OAS31 - Oral Abstract Session 31	OAS32 - Oral Abstract Session 32	FT32 - Flash Talk Session 32	FT33 - Flash Talk Session 33		TPS - Poster Session
30
13:00
30	SY11 - T2 inflammation in the upper airways: from bench to bedside		SY12 - Food allergy: from prevention to prediction of therapeutic responses	TSY3 - Autoimmunity in allergic diseases: implications for treatment			SY13 - Therapeutic options in indolent systemic mastocytosis: a roadmap	SSS 4 - EAACI & ACAAI Joint Symposium : Unified Airway Disease		OAS07 - Insights in pediatric allergy: from bench to bedside	OAS08 - Phenotypes and mechanisms in asthmatic diseases	FT08 - Biological treatment in asthmatic diseases	FT09 - Allergen immunotherapy in clinical studies	P & C 3 - Is remission an adequate therapeutic goal for severe asthma
14:00					ET 2 - EAACI Enlightening Talks - 2
30														P & C 4 - Should dupilumab be the standard first treatment choice for severe atopic dermatitis?
15:00	SY14 - Sustainable diets the gut microbiome and the immune		SY15 - Airway immune metabolism in allergic diseases	TSY4 - Climate Change and Insect allergy	OAS-CT2 - Clinical Trials on Dermatology		SSS 5 - EAACI & AAAAI Joint Symposium – Atopic Dermatitis 2025: Novel Pathophysiology & Treatment Insights			OAS09 - Progress in understanding the mechanisms of airborne allergen immunotherapy	OAS10 - Understanding of mechanisms of food immunotherapy	FT10 - Skin and allergy	FT11 - Biologics and airway disease in pediatric care
30
16:00
30
17:00	SY16 - Healthier planet, healthier people: the recipe for a sustainable future		SY17 - Non-allergic comorbidities in allergic patients	SY18 - Th2 immune responses and clinical outcomes	IH4 - Artificial intelligence in allergy and health: from analytics to patient interaction	IWS8 - Interpreting clinical and laboratory signs of mastocytosis				OAS11 - Clinical and immunological aspects in allergen immunotherapy	OAS12 - New trends in atopic dermatitis	FT12 - Early-life influences on allergy and immune development	FT13 - Basic research in food allergy	YIR - YIR 1
30
18:00
30
19:00

Scientific

	Clyde Auditorium	Poster Zone	Lomond Auditorium	Hall 1	Innovation Hub	Meeting Academy M1	Forth	Boisdale	Alsh	Carron 1	Carron 2	Dochart 1	Dochart 2	EAACI Global Stage	Poster Area


7:00
30
8:00										MTE 9 - Management of the reactions to inodiated contrast media	MTE 10 - Mast cell activation test and food allergy	MTE11 - Improve statistics to analyse your data	MTE12 - Recent advances in natural killer cells and innate lymphoid cells
30
9:00	SY19 - Atopic dermatitis; the other side of the mirror		SY20 - Present and future of allergen immunotherapy	SY21 - Very early nutrition and allergy outcomes	IH5 - Telemedicine	IWS9 - How to manage asthma patients in the clinic	IWS10 - Management of hypersensitivity to chemotherapy	SSS 6 - EAACI & KAAACI Joint Symposium : New horizons toward controlling allergy and allergens	TSY 5 - The role of mucus in asthma and CRS severity	OAS13 - Diagnosis and management of Eosinophilic Esophagitis	OAS14 - Natural history and treatment of food allergy	FT14 - Allied health and primary care	FT15 - The Heterogenicity of asthma	JMA5 - JM-NAS Symposium : Early life exposure and allergy development
30
10:00
30
11:00	PL7 - New horizons in the management of severe atopic dermatitis		PL8 - One Health: Addressing Environmental Challenges in Allergy and Immunology	PL9 - Highlights of EAACI Task Forces: Bridging Innovation and Clinical Practice
30
12:00
30
13:00		TPS75 - Prevention TPS71 - Mastocytosis and mast cells TPS72 - Insect venom hypersensitivities TPS65 - Immune deficiencies and autoimmunity 03 TPS60 - Food allergy 05 TPS59 - Food allergy 04 TPS74 - Epithelial cell biology TPS70 - Eosinophilic esophagitis TPS62 - Drug allergy 05 TPS61 - Drug allergy 04 TPS64 - Dermatology 04 TPS68 - Biomarkers TPS67 - Biologicals 03 TPS66 - Basic immunology 03 TPS57 - Asthma 08 TPS56 - Asthma 07 TPS55 - Asthma 06 TPS73 - Artificial Intelligence TPS63 - Anaphylaxis 04 TPS69 - Allied health and primary care TPS54 - Allergy diagnosis 13 TPS53 - Allergy diagnosis 12 TPS52 - Allergy diagnosis 11 TPS51 - Allergy diagnosis 10 TPS58 - Allergen immunotherapy 05		SSS 7 - EAACI & APAAACI Joint Symposium : Recent Developments in Environmental Issues, Allergic Diseases, and Vaccination in Asia Pacific	PiS01 - A booster for our (interconnected) future					OAS33 - Oral Abstract Session 33	OAS34 - Oral Abstract Session 34	FT34 - Flash Talk Session 34	FT35 - Flash Talk Session 35		TPS - Poster Session
30
14:00	SY22 - Crosstalk between lung structural cells and immune cells in airway inflammation and remodeling		SY23 - Breakthroughs Biologicals in allergic diseases	TSY6 - Molecular mapping of asthma: Decoding airway remodelling for targeted interventions	ET 3 - EAACI Enlightening Talks - 3			JMA6 - JM Sister Societies Symposium		OAS15 - Outcomes in chronic rhinosinusitis and type 2 inflammation	OAS16 - Efficacy and safety of allergen immunotherapy in clinical practice	FT16 - Immunodeficiencies and autoimmunity	FT17 - Predictive value of allergy test	P & C 5 - Should we be concerned when starting allergen immunotherapy in patients with controlled HIV infection or autoimmune diseases?
30						GBD2 - Ground breaking discoveries 2	SSS 8 - EAACI & WAO Joint Symposium - Improved approaches in food allergy
15:00														P & C 6 - Sting challenge test
30
16:00	SY24 - A practical approach to chronic urticaria		SY25 - Breathing Easier: Cutting-Edge Advances in Paediatric Asthma Management	SY26 - Epithelial cell biology and barrier regeneration	OAS-CT3 - OAS - Clinical Trial Session 3	IWS11 - Food Allergy Management	SSS 9 - EAACI & IPCRG Joint Symposium : Rhinitis Right Care: how to gain interest, confidence and competence in good quality primary care	IWS12 - Environmental impact of asthma treatment: prioritizing patient outcomes and reducing environmental burden		OAS17 - Allergy diagnosis using in-vitro assays	OAS18 - Immunodeficiencies and autoimmunity	FT18 - Mechanisms in asthma: understanding the disease	FT19 - New insights on allergen immunotherapy
30
17:00
30	SY27 - Diagnostic Challenges in Patients with Inborn Errors of Immunity with Different Manifestations of Immune Dysregulation		SY28 - Eosinophilic esophagitis: Exploring local responses, immune mechanisms, and clinical diversity	TSY7 - Epithelial dynamics and barrier function		IWS14 - Updates on contact dermatitis and patch testing	YIR - YIR 2	JMA 7 - JM Case report		OAS19 - Treatment response in severe asthma: from rehabilitation to biologic	OAS20 - Allergen specific diagnostic testing	FT20 - Practical advances in food allergy and management	FT21 - Allergic rhinitis: updates on epidemiology, diagnostics, and novel therapy
18:00
30
19:00

Scientific

	Clyde Auditorium	Lomond Auditorium	Hall 1	Meeting Academy M1	Forth	Boisdale	Alsh	Carron 1	Carron 2	Dochart 1	Dochart 2


9:00	PL10 - Precision Medicine in Airway Diseases: Biomarkers and Phenotyping	PL11 - Biologicals in Allergy and Asthma: Where Are We?
30
10:00
30
11:00	SY29 - War related exposures and asthma development	SY30 - Rare cases in paediatric allergy clinical practice	SY31 - Early life Immuno modulation	SY32 - Periocular and ocular surface disorders: Beyond What Meets the Eye	IWS15 - Methodology of Allergen challenges for airway allergy	IWS16 - Time to redefine healthy eating?	SY37 - Biomarkers for asthma and allergic diseases	OAS21 - Update on major food allergies	OAS22 - Clinical Management	FT22 - Chronic rhinosinusitis: from bedside to bench	FT23 - News in hereditary angioedema management
30
12:00
30	SY33 - Drug allergy during childhood	SY34 - Focus on exercise and asthma management	SY35 - Updates in the clinical management of allergen immunotherapy	SY36 - Communication with allergic patients in primary care	IWS18 - Innovations in angioedema diagnosis	IWS19 - Food Allergy in Clinical Practice	TSY8 - Allergenic risk of novel foods	OAS23 - Predicting pediatric asthma and airway disease	OAS24 - Clinical aspects of chronic urticaria	FT24 - Aerobiology and Climate change: something is blowing in the wind	FT25 - Pre-clinical modeling of allergic and asthmatic diseases
13:00
30
14:00
30	Closing Ceremony
15:00

Last updated
03.04.2025, 09:21

EAACI Congress 2025

Share this pen